TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34403137

Group type: EXPERIMENTAL
Intervention: Stimulation intervention with or without supplementation (n=48)
Number of subjects: 127

Group type: COMPARATOR
Intervention: No-treatment (no-intervention and supplementation only, n=47)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Comparison group (children without stunted growth, n=64)
Number of subjects: 127
Study: 33478563

Group type: EXPERIMENTAL
Intervention: Robotic therapy (1 hour per day for 10 days)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (standard of care therapy only)
Number of subjects: 19
Study: 35072431

Group type: EXPERIMENTAL
Intervention: Remimazolam-propofol-sufentanil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propofol-sufentanil
Number of subjects: 0
Study: 33929533

Group type: EXPERIMENTAL
Intervention: Aerobic and resistance exercise intervention (16 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 36117971

Group type: EXPERIMENTAL
Intervention: Remimazolam with alfentanil (group RA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Propofol with alfentanil (group PA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 35042638

Group type: EXPERIMENTAL
Intervention: Mobile phone reminders (SMS and follow-up calls) sent three days to and on the due date of the child's schedule for the 1st, 2nd, and 3rd doses of the pentavalent vaccine.
Number of subjects: 541

Group type: COMPARATOR
Intervention: Control group (no mobile phone reminders).
Number of subjects: 541
Study: 34487764

Group type: EXPERIMENTAL
Intervention: Elective nodal irradiation (ENI) using ultra-hypofractionated radiation (UHRT) (25 Gy in 5 weekly fractions)
Number of subjects: 165
Study: 616083505

Group type: EXPERIMENTAL
Intervention: 5% Betadine
Number of subjects: 20
Study: 32907642

Group type: EXPERIMENTAL
Intervention: Minding the Baby (MTB) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33188398

Group type: EXPERIMENTAL
Intervention: Biofortified orange-fleshed sweetpotato
Number of subjects: 59

Group type: COMPARATOR
Intervention: Regular orange-fleshed sweetpotato
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Biofortified purple-fleshed potato
Number of subjects: 59

Group type: COMPARATOR
Intervention: Regular yellow-fleshed potato
Number of subjects: 59
Study: 35260463

Group type: EXPERIMENTAL
Intervention: Eptinezumab
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous lignocaine
Number of subjects: 40
Study: 33522839

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin treatment
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Fosfomycin treatment
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Included patients
Number of subjects: 513

Group type: COMPARATOR
Intervention: Excluded patients
Number of subjects: 513
Study: 32649733

Group type: EXPERIMENTAL
Intervention: Continuous speech with 0 dB SNR
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Continuous speech with -5 dB SNR
Number of subjects: 8
Study: 36274805

Group type: EXPERIMENTAL
Intervention: USG-guided out-of-plane approach to right IJV cannulation
Number of subjects: 110

Group type: COMPARATOR
Intervention: USG-guided supraclavicular in-plane approach to right BCV cannulation
Number of subjects: 110
Study: 32035748

Group type: EXPERIMENTAL
Intervention: EchoEducator smartphone application
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard intraoperative teaching
Number of subjects: 30
Study: 35275852

Group type: EXPERIMENTAL
Intervention: Braces with pressure points at the apical vertebra level
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Braces with ventral support
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Braces with upper straps positioned above T10
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Lateral and ventral skin‐to‐brace pressures
Number of subjects: 72
Study: 34146026

Group type: COMPARATOR
Intervention: Conventional hydration (CH)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Anterior stromal pocket hydration (ASPH)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Modified stromal pocket hydration (MASH)
Number of subjects: 90

Group type: COMPARATOR
Intervention: ASPH and MASH compared to CH
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: ASPH
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 32842052

Group type: EXPERIMENTAL
Intervention: E2/P4 hormone therapy (TX-001HR)
Number of subjects: 1340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1340
Study: 34788454

Group type: EXPERIMENTAL
Intervention: Zao Ren An Shen (ZRAS) capsule
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 36377643

Group type: EXPERIMENTAL
Intervention: High dose Zika vaccine (6 antigen units)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Low dose Zika vaccine (3 antigen units)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 32278858

Group type: EXPERIMENTAL
Intervention: 80 mg/d of purified anthocyanins
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Increasing doses of purified anthocyanins
Number of subjects: 111
Study: 35965392

Group type: EXPERIMENTAL
Intervention: Lotilaner ophthalmic solution, 0.25%
Number of subjects: 421

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 421
Study: 32838478

Group type: EXPERIMENTAL
Intervention: ipilimumab
Number of subjects: 5465

Group type: EXPERIMENTAL
Intervention: ipinivo
Number of subjects: 5465

Group type: EXPERIMENTAL
Intervention: nivolumab
Number of subjects: 5465

Group type: COMPARATOR
Intervention: pembrolizumab
Number of subjects: 5465
Study: 32916347

Group type: EXPERIMENTAL
Intervention: NMES active on leg ipsilateral to SSEP acquisition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NMES active on leg contralateral to SSEP acquisition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham (NMES inactive)
Number of subjects: 0
Study: 36477809

Group type: EXPERIMENTAL
Intervention: NYHA class I
Number of subjects: 8326

Group type: EXPERIMENTAL
Intervention: NYHA class III
Number of subjects: 8326

Group type: EXPERIMENTAL
Intervention: NYHA class II
Number of subjects: 8326

Group type: EXPERIMENTAL
Intervention: NYHA class I with high NT-proBNP levels
Number of subjects: 8326
Study: 33442904

Group type: EXPERIMENTAL
Intervention: Iron infusion (iron (iii)-hydroxide sucrose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Iron chelation (desferrioxamine)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Exercise at 25% peak wattage
Number of subjects: 20
Study: 32700220

Group type: EXPERIMENTAL
Intervention: Peer coach-led intervention for chronic pain (6 months, contact twice per month)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control group (2-hour pain self-management class)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Peer coach-led intervention
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 215
Study: 34263647

Group type: EXPERIMENTAL
Intervention: Acupuncture at the Zhongji (RN3) acupoint for 10 minutes
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham acupuncture for 10 minutes
Number of subjects: 72
Study: 33072197

Group type: EXPERIMENTAL
Intervention: Cerebrolysin, 50 mL per day for ten days, followed by two treatment cycles with 10 mL per day for ten days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cerebrolysin
Number of subjects: 80
Study: 36148451

Group type: EXPERIMENTAL
Intervention: Paxlovid
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control
Number of subjects: 142
Study: 35419726

Group type: EXPERIMENTAL
Intervention: Guihuang Formula (GHF)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Tamsulosin
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 33863716

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (rtCGM)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (Control)
Number of subjects: 135
Study: 36250147

Group type: EXPERIMENTAL
Intervention: PRO+CHO
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CHO+PRO
Number of subjects: 10

Group type: COMPARATOR
Intervention: CHO+CHO
Number of subjects: 10
Study: 33987442

Group type: EXPERIMENTAL
Intervention: Orthodontic metal brackets
Number of subjects: 40

Group type: COMPARATOR
Intervention: No brackets (Control)
Number of subjects: 40
Study: 32752149

Group type: EXPERIMENTAL
Intervention: Diet and physical activity interventions to limit gestational weight gain (GWG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diet and physical activity interventions to limit GWG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal GWG recommendations based on pre-pregnancy BMI categories
Number of subjects: 0
Study: 35120184

Group type: EXPERIMENTAL
Intervention: Fronto-occipital transcranial alternating current stimulation (tACS) - anti-phase
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fronto-occipital transcranial alternating current stimulation (tACS) - in-phase
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fronto-occipital transcranial alternating current stimulation (tACS) - control
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Weekly assessments of Dizziness Handicap Inventory (DHI), MdDS Balance Rating Scale (MBRS), and Hospital Anxiety and Depression Scale (HADS)
Number of subjects: 24
Study: 33655352

Group type: EXPERIMENTAL
Intervention: Blood group A
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Malaria positive cases
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Anemia prevalence
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Risk factors for malaria
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Overall malaria prevalence
Number of subjects: 390
Study: 32708991

Group type: EXPERIMENTAL
Intervention: High-Dairy Diet (HDD) (5–6 dairy portions per day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Low-Dairy Diet (LDD) (≤1 dairy portion per day)
Number of subjects: 46
Study: 35143644

Group type: COMPARATOR
Intervention: CsA/MPA
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: PT-Cy/CsA
Number of subjects: 160
Study: 34383532

Group type: EXPERIMENTAL
Intervention: Cognitive bias modification (CBM)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control
Number of subjects: 230
Study: 32933775

Group type: EXPERIMENTAL
Intervention: SU-ERm: etch-and-rinse + moist dentin
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: SU-ERd: etch-and-rinse + dry dentin
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: SU-Set: selective enamel etching
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: SU-SE: self-etch
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: SU-ERm and SU-ERd
Number of subjects: 39
Study: 36166463

Group type: EXPERIMENTAL
Intervention: efavirenz-based ART
Number of subjects: 62

Group type: COMPARATOR
Intervention: raltegravir-based ART
Number of subjects: 62
Study: 34476783

Group type: EXPERIMENTAL
Intervention: Double-bundle (DB) ACL reconstruction
Number of subjects: 38

Group type: COMPARATOR
Intervention: Single-bundle (SB) ACL reconstruction
Number of subjects: 38
Study: 36282051

Group type: EXPERIMENTAL
Intervention: Intralesional MMR vaccine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intralesional PPD injections
Number of subjects: 40
Study: 33331957

Group type: EXPERIMENTAL
Intervention: Digital pen tests (DPT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Manual results (MR)
Number of subjects: 40
Study: 33020098

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) therapy for depression
Number of subjects: 0
Study: 33932411

Group type: EXPERIMENTAL
Intervention: poly (I:C) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quantitative real-time PCR (qRT-PCR) analysis of immune response genes
Number of subjects: 0
Study: 32390092

Group type: EXPERIMENTAL
Intervention: 0.454% stannous fluoride dentifrice
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.243% sodium fluoride dentifrice
Number of subjects: 30
Study: 32829966

Group type: EXPERIMENTAL
Intervention: Longer telomeres
Number of subjects: 37688

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 37688
Study: 33159796

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (60, 40, 30, 20, 15, and 10 mg daily for 1 week each, followed by 5 mg daily for 18 weeks)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (same regimen as prednisolone)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Oral prednisolone
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 32921501

Group type: EXPERIMENTAL
Intervention: High-dose pitavastatin (4 mg/d)
Number of subjects: 313

Group type: COMPARATOR
Intervention: Usual dose pitavastatin (2 mg/d)
Number of subjects: 313
Study: 35022459

Group type: EXPERIMENTAL
Intervention: Preemptive ultrasound-guided transversus abdominis plane (TAP) block with 20 cc of ropivacaine 0.25%
Number of subjects: 76

Group type: COMPARATOR
Intervention: Postoperative ultrasound-guided transversus abdominis plane (TAP) block with 20 cc of ropivacaine 0.25%
Number of subjects: 76
Study: 34217259

Group type: EXPERIMENTAL
Intervention: Supported Education intervention given by a Supported Education specialist
Number of subjects: 100

Group type: COMPARATOR
Intervention: Support as usual plus advice from a trained staff member on potential supportive resources regarding studying with mental health problems
Number of subjects: 100
Study: 36014954

Group type: EXPERIMENTAL
Intervention: Integrative Nutrition Package (INP) through home visits
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard procedure (Control group)
Number of subjects: 60
Study: 33471039

Group type: EXPERIMENTAL
Intervention: Liraglutide 3 mg/d
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 35545781

Group type: EXPERIMENTAL
Intervention: Bevacizumab + Paclitaxel + Carboplatin (Group B)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Paclitaxel + Carboplatin (Group A)
Number of subjects: 68
Study: 32413238

Group type: COMPARATOR
Intervention: Test product (5-mg olanzapine ODT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference product (5-mg olanzapine ODT)
Number of subjects: 48
Study: 36372657

Group type: EXPERIMENTAL
Intervention: Tailored sleep health education (10 brief education modules)
Number of subjects: 678

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 678
Study: 33677520

Group type: EXPERIMENTAL
Intervention: Hula-based intervention (n = 131)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Education-only waitlist control (n = 132)
Number of subjects: 263
Study: 33170854

Group type: EXPERIMENTAL
Intervention: Public Health Clinic Patient Satisfaction Questionnaire (PHC‐PSQ)
Number of subjects: 400
Study: 34924332

Group type: EXPERIMENTAL
Intervention: Neuro-emotional technique (NET)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 33218372

Group type: EXPERIMENTAL
Intervention: Right leg landing
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Left leg landing
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Dynamic postural stability
Number of subjects: 32
Study: 37258803

Group type: EXPERIMENTAL
Intervention: Dapagliflozin + Sitagliptin + Metformin ER (10 mg + 100 mg + 1000 mg)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Sitagliptin + Metformin SR (100 mg + 1000 mg)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Dapagliflozin + Metformin ER (10 mg + 1000 mg)
Number of subjects: 415
Study: 33522698

Group type: EXPERIMENTAL
Intervention: 2000 IU per day of vitamin D
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 36260470

Group type: EXPERIMENTAL
Intervention: Bioactive resin-modified glass ionomer (ACTIVA BioACTIVE restorative)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Giomer hybrid composite (Beautifil Flow Plus)
Number of subjects: 50
Study: 32975600

Group type: EXPERIMENTAL
Intervention: Transarterial radioembolization (TARE) using SIR‐Spheres yttrium‐90 resin microspheres
Number of subjects: 200
Study: 32735216

Group type: EXPERIMENTAL
Intervention: BroHealth web‐based mental health program with BroMatters website access
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: BroHealth web‐based mental health program with BroMatters website access and telephone sessions with a life coach
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: HardHat web‐based mental health program
Number of subjects: 77

Group type: COMPARATOR
Intervention: General depression information from BroMatters website
Number of subjects: 77

Group type: COMPARATOR
Intervention: HardHat web‐based mental health program (post-RCT access)
Number of subjects: 77
Study: 33932394

Group type: EXPERIMENTAL
Intervention: 1 mL of 5 μg.mL‐1 sufentanil (group S) with 30 mL of 0.5% bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1 mL of 100 μg.mL‐1 dexmedetomidine (group D) with 30 mL of 0.5% bupivacaine
Number of subjects: 40
Study: 33525934

Group type: EXPERIMENTAL
Intervention: Transcranial Infrared Laser Stimulation (TILS)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Sham control (not explicitly detailed in the abstract)
Number of subjects: 5
Study: 32369401

Group type: EXPERIMENTAL
Intervention: Text Messaging (TM)
Number of subjects: 702

Group type: COMPARATOR
Intervention: No Text Messaging (No-TM)
Number of subjects: 702
Study: 35767915

Group type: EXPERIMENTAL
Intervention: AST-120
Number of subjects: 149
Study: 34160286

Group type: EXPERIMENTAL
Intervention: Milk
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Green tea
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cola
Number of subjects: 50

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 50
Study: 33047540

Group type: EXPERIMENTAL
Intervention: Y-STR genetic markers (27 markers)
Number of subjects: 1702

Group type: EXPERIMENTAL
Intervention: DYS385
Number of subjects: 1702

Group type: EXPERIMENTAL
Intervention: DYS438
Number of subjects: 1702

Group type: EXPERIMENTAL
Intervention: Y-Predictor software
Number of subjects: 1702
Study: 33771763

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12, 10^9 colony-forming units, orally, once daily for 6 months
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12
Number of subjects: 96
Study: 36335645

Group type: EXPERIMENTAL
Intervention: Mavacamten
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 33562861

Group type: EXPERIMENTAL
Intervention: Flipped-Mastery Contact Model (FMCM)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Flipped-Mastery Untact Model (FMUM)
Number of subjects: 85
Study: 32519219

Group type: EXPERIMENTAL
Intervention: VOCAL-Penn model for ACLF development at 3 months
Number of subjects: 75922

Group type: EXPERIMENTAL
Intervention: VOCAL-Penn model for ACLF development at 6 months
Number of subjects: 75922

Group type: EXPERIMENTAL
Intervention: VOCAL-Penn model for ACLF development at 12 months
Number of subjects: 75922

Group type: EXPERIMENTAL
Intervention: VOCAL-Penn model for ACLF mortality at 28 days
Number of subjects: 75922

Group type: EXPERIMENTAL
Intervention: VOCAL-Penn model for ACLF mortality at 90 days
Number of subjects: 75922

Group type: COMPARATOR
Intervention: Comparison with MELD, MELD-sodium, and APASL ACLF scores
Number of subjects: 75922
Study: 33340514

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Low-load Resistance Training with Blood Flow Restriction (RT+BFR)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control Group (CTL)
Number of subjects: 90
Study: 33186351

Group type: EXPERIMENTAL
Intervention: Baseline MRI findings
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Follow-up MRI findings after two months
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Presence of multiple brain lesions
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Baseline and follow-up MRI findings and paradoxical responses
Number of subjects: 48
Study: 36239287

Group type: EXPERIMENTAL
Intervention: Low carbohydrate, high fat (LCHF) diet
Number of subjects: 14

Group type: COMPARATOR
Intervention: High carbohydrate (HC) diet
Number of subjects: 14
Study: 33398914

Group type: EXPERIMENTAL
Intervention: Methotrexate (n = 667)
Number of subjects: 926

Group type: COMPARATOR
Intervention: Azathioprine (n = 259)
Number of subjects: 926
Study: 32449396

Group type: EXPERIMENTAL
Intervention: New brochure
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Community health worker (CHW) delivered new brochure's content
Number of subjects: 240

Group type: COMPARATOR
Intervention: Standard educational brochure (Control)
Number of subjects: 240
Study: 37645033

Group type: EXPERIMENTAL
Intervention: Aripiprazole as adjunctive therapy with valproate sodium
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Risperidone as adjunctive therapy with valproate sodium
Number of subjects: 64
Study: 33948768

Group type: EXPERIMENTAL
Intervention: PCOS group (n = 41)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 54
Study: 35403396

Group type: EXPERIMENTAL
Intervention: Eye acupuncture + Tengliao + rehabilitation
Number of subjects: 356

Group type: COMPARATOR
Intervention: Tengliao + rehabilitation
Number of subjects: 356

Group type: COMPARATOR
Intervention: Rehabilitation
Number of subjects: 356
Study: 34126858

Group type: EXPERIMENTAL
Intervention: eCHECKUP TO GO (eCTG) intervention
Number of subjects: 227

Group type: COMPARATOR
Intervention: Healthy Stress Management (HSM) control
Number of subjects: 227
Study: 34373987

Group type: EXPERIMENTAL
Intervention: Household water insecurity score (5-unit increase)
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Household water insecurity
Number of subjects: 716
Study: 34927590

Group type: EXPERIMENTAL
Intervention: Wearable activity tracker + 6 weekly behavioral support emails
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Wearable activity tracker
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (copy of Canadian PA guidelines only)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 49
Study: 32875989

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 172

Group type: COMPARATOR
Intervention: Liraglutide
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Dapagliflozin and Liraglutide
Number of subjects: 172